Browse the evidence

Modified alternate-day fasting in obese women leads to a statistically significant decrease in HDL cholesterol, which may counteract some cardiovascular benefits.

Be aware that while this fasting protocol lowers bad cholesterol and blood pressure, it may also lower 'good' (HDL) cholesterol in obese women. The net health benefit is likely positive due to larger reductions in LDL and BP, but monitoring lipid profiles is recommended.

Routine screening for Obstructive Sleep Apnea (OSA) in PCOS is not recommended for the purpose of improving cardiometabolic risk, as there is inadequate evidence for metabolic benefits of OSA treatment in PCOS.

If you have PCOS and suspect sleep apnea (snoring, daytime sleepiness), get it treated to improve your energy and mood. However, do not expect treating sleep apnea to fix your blood sugar or cholesterol levels; focus on lifestyle changes for those metabolic goals.

Childhood sleep problems predict higher levels of depression and anxiety, but this relationship is not bidirectional (depression does not predict childhood sleep problems).

For children with persistent sleep issues, prioritize sleep hygiene and evaluation early, as this is a risk factor for developing depression and anxiety later. Treating sleep may mitigate this risk.

Immunosenescence and inflamm-aging are not merely detrimental processes but are adaptive, energy-conserving mechanisms that support longevity by prioritizing survival over rapid pathogen eradation.

Do not assume that 'boosting' your immune system to youthful levels is always beneficial for longevity. The aging immune system undergoes 'immunoremodeling' to save energy and reduce oxidative stress, which may support a longer life. Focus on maintaining homeostasis and managing inflammation rather than aggressively trying to restore youthful immune metrics.

Telomere length is a valid biological age predictor that correlates with mortality, particularly for cancer and cardiovascular disease, and is independent of epigenetic clocks, though its predictive power varies by cancer type and sex.

Telomere length is a useful marker for cardiovascular and specific cancer risks, but it is not a magic bullet for overall cancer prevention. Women naturally have longer telomeres, which may contribute to longevity. While you cannot directly 'lengthen' telomeres safely with current supplements, maintaining cardiovascular health and avoiding smoking may support telomere integrity. It is one piece of the puzzle, not the whole picture.

Composite biomarker predictors, which combine multiple clinical and biochemical markers (e.g., CRP, creatinine, blood pressure), are effective biological age predictors that correlate with mortality, physical function, and cognitive decline, often outperforming single biomarkers like telomere length.

Composite biomarker scores, which combine multiple blood tests and clinical measures (like blood pressure and cholesterol), are powerful tools for assessing biological age. They often predict health outcomes and mortality better than single markers. While more complex to obtain, they provide a more comprehensive view of your systemic health than a single test, helping to identify risks that might be missed by looking at one factor alone.

Gut microbiota composition and activity directly influence central nervous system function, behavior, and stress responsiveness through bidirectional signaling via neural, endocrine, and immune pathways.

Your gut health is connected to your brain health through multiple biological pathways (nerves, hormones, immune system). While you can't just take a probiotic to cure depression or anxiety, maintaining a diverse microbiome through a fiber-rich diet may support overall brain and gut function. Be skeptical of claims that a specific probiotic will fix mental health issues, as human results are inconsistent. Focus on long-term dietary patterns rather than quick fixes.

Telomere erosion is a primary driver of senescence and aging, although its relative importance varies between species.

Telomere shortening contributes to cellular aging, but it is not the only factor. Other mechanisms like metabolic dysfunction and inflammation also play critical roles. A holistic approach to health is necessary.

Senolytic drugs (e.g., Dasatinib + Quercetin) reduce senescent cell burden and improve healthspan parameters in aged, radiation-exposed, and progeroid mice, though clinical use is limited by side effects like neutropenia.

Senolytic drugs like Dasatinib and Quercetin show promise in animal models for improving healthspan and reducing senescent cells. However, human application is currently limited by side effects like blood cell count reduction. This is an emerging field, not yet a standard recommendation for healthy individuals.

SASP modulation (senomorphics) offers an alternative to senolytics by targeting the secretome rather than killing cells, with potential benefits for wound healing and fibrosis where cell clearance might be harmful.

Instead of killing senescent cells, some therapies aim to reduce their harmful secretions (SASP). Drugs like Metformin and Rapamycin may have these effects, but their benefits are not solely due to SASP modulation. This approach may be safer in contexts where some senescent cells are needed for healing.

Inducing senescence in cancer cells (prosenescence) followed by senolytic clearance ('one-two punch') or immune potentiation can improve cancer treatment outcomes by exploiting vulnerabilities of senescent tumor cells.

For cancer patients, combining standard treatments with senolytics is a promising strategy being studied in labs. It aims to kill cancer cells and then clear the remaining damaged ones. This is not yet a standard of care.

High levels of Reactive Oxygen Species (ROS) are causally linked to the induction and maintenance of cell senescence, which drives aging and age-related diseases, whereas low ROS levels are associated with extended organismal lifespan.

Focus on maintaining natural redox balance rather than relying on high-dose antioxidant supplements, which may be ineffective or harmful. The paper highlights that moderate ROS levels (e.g., from exercise) can be beneficial (mitohormesis), while chronic high ROS (from stress, smoking, poor diet) drives aging. Strategies like caloric restriction and exercise are mentioned as ways to reduce OS and extend lifespan.

Genetic variations in the AQP4 water channel gene affect sleep architecture, tolerance to sleep deprivation, and the rate of cognitive decline in Alzheimer's disease, with specific polymorphisms linked to faster or slower progression.

If you have a family history of Alzheimer's, consider discussing genetic testing for AQP4 polymorphisms with your doctor. Understanding your genetic risk may help tailor sleep and cardiovascular strategies to protect your brain health.

Antibiotic treatment for severe acute malnutrition (SAM) can improve nutritional recovery and reduce mortality, likely by altering the microbiome to improve nutrient extraction, although the mechanism is not fully understood.

For children with severe acute malnutrition, antibiotic treatment (amoxicillin or cefdinir) for one week is a standard, life-saving part of care that improves recovery. This is distinct from general antibiotic use and targets the specific dysbiotic state of malnutrition.

Higher fecal abundance of Staphylococcus, Enterobacteriaceae, and Escherichia coli in pregnant women is associated with unfavorable biochemical markers, including higher total cholesterol, higher ferritin, and lower transferrin.

In pregnant women, higher levels of E. coli and Staphylococcus are associated with higher cholesterol and markers of iron dysregulation (high ferritin, low transferrin). This may reflect an inflammatory state associated with obesity. Maintaining a healthy weight and diet may help keep these bacterial populations in check, supporting better metabolic health.

Exercise does not reduce mortality or amputation rates in patients with intermittent claudication.

While exercise won't necessarily prevent amputation or death based on current data, it is still recommended because it significantly improves your quality of life and walking ability. Focus on the functional benefits rather than expecting it to cure the underlying arterial disease.

Low-grade systemic inflammation, driven by hepatic cytokine production, visceral adipose tissue, and gut microbiota metabolites (like TMAO), is a key pathophysiological mechanism linking NAFLD to cardiovascular disease and arrhythmias.

Managing NAFLD involves reducing systemic inflammation through weight loss, dietary changes (reducing saturated fats and processed meats which affect gut microbiota), and exercise. This reduces the inflammatory burden on your blood vessels and heart.

Corporate strategies prioritizing shareholder value maximization over public health actively propagate non-communicable diseases through marketing, lobbying, supply chain expansion, and corporate social responsibility, creating an environment where unhealthy products are more available, desirable, and affordable.

To improve population health, policy must target corporate practices rather than just individual behavior. This involves supporting regulations on marketing, lobbying transparency, and supply chain accountability, particularly in low- and middle-income countries where market penetration is growing.

Resistance training has small effects on muscle morphology (mass/size) in older adults, and no single training volume variable significantly predicts these morphological changes.

If your goal is muscle size (not just strength), expect small gains. Use moderate weights (51-69% 1RM), train 3 times a week, and rest 120 seconds between sets. Focus on long-term consistency (over a year) rather than specific volume metrics, as no single volume variable strongly predicts muscle growth in older adults.

Patients with non-alcoholic steatohepatitis (NASH) exhibit a significantly lower relative abundance of Bacteroidetes in their intestinal microbiota compared to healthy controls and those with simple steatosis, an association that persists independently of BMI and dietary fat intake.

If you have NASH, your gut bacteria profile is likely distinct from healthy individuals, specifically showing lower levels of Bacteroidetes. This difference is not just because of being overweight or eating fat, but is linked to the liver inflammation itself. While this paper doesn't prescribe a fix, it highlights that restoring gut balance (potentially through fiber or specific prebiotics that support Bacteroidetes) might be a relevant therapeutic avenue to discuss with your hepatologist, separate from weight loss efforts.

Blueberry consumption improves cognitive function and slows cognitive decline in older adults, particularly those with mild cognitive impairment.

If you are concerned about memory or cognitive decline, adding blueberries to your diet may help. Studies suggest that eating blueberries daily for several months can improve memory and executive function, especially in older adults.

For prediabetes prevention, neither exercise nor drug interventions show statistically significant mortality benefits compared to control or each other.

Current evidence does not show that exercise or drugs significantly reduce mortality risk in people with prediabetes. Focus on other proven health benefits of exercise (e.g., functional capacity, muscle strength) rather than mortality prevention for this specific group.

Small molecule-based therapies and reprogramming strategies can ameliorate or reverse aging-related conditions by manipulating epigenetic mechanisms.

Epigenetic rejuvenation therapies are being developed. Consult a healthcare provider for emerging treatments.

Dietary fiber fermentation outcomes (SCFA profile and quantity) are determined by the host's gut microbiota enterotype (Prevotella- vs. Bacteroides-dominated), meaning identical fiber substrates produce different health-relevant metabolites depending on individual microbiome composition.

If you are trying to optimize gut health with fiber, recognize that your unique gut bacteria dictate the outcome. A fiber that boosts satiety-signaling propionate in one person might produce different effects in another. Personalized fiber choices based on microbiome testing may be necessary for specific health goals, as generic fiber advice ignores these biological differences.